Lisata Therapeutics Statistics
Total Valuation
LSTA has a market cap or net worth of $22.15 million. The enterprise value is -$252,029.
Important Dates
The next estimated earnings date is Tuesday, November 11, 2025, after market close.
| Earnings Date | Nov 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
LSTA has 8.76 million shares outstanding. The number of shares has increased by 3.15% in one year.
| Current Share Class | 8.76M |
| Shares Outstanding | 8.76M |
| Shares Change (YoY) | +3.15% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 17.09% |
| Owned by Institutions (%) | 8.94% |
| Float | 7.26M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 19.26 |
| Forward PS | n/a |
| PB Ratio | 1.00 |
| P/TBV Ratio | 1.04 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.77, with a Debt / Equity ratio of 0.00.
| Current Ratio | 5.77 |
| Quick Ratio | 5.37 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -64.40% and return on invested capital (ROIC) is -44.46%.
| Return on Equity (ROE) | -64.40% |
| Return on Assets (ROA) | -38.76% |
| Return on Invested Capital (ROIC) | -44.46% |
| Return on Capital Employed (ROCE) | -100.74% |
| Revenue Per Employee | $41,154 |
| Profits Per Employee | -$727,808 |
| Employee Count | 26 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -962,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.64% in the last 52 weeks. The beta is 1.04, so LSTA's price volatility has been similar to the market average.
| Beta (5Y) | 1.04 |
| 52-Week Price Change | -12.64% |
| 50-Day Moving Average | 2.42 |
| 200-Day Moving Average | 2.54 |
| Relative Strength Index (RSI) | 57.81 |
| Average Volume (20 Days) | 42,966 |
Short Selling Information
The latest short interest is 38,114, so 0.44% of the outstanding shares have been sold short.
| Short Interest | 38,114 |
| Short Previous Month | 15,493 |
| Short % of Shares Out | 0.44% |
| Short % of Float | 0.53% |
| Short Ratio (days to cover) | 1.57 |
Income Statement
In the last 12 months, LSTA had revenue of $1.07 million and -$18.92 million in losses. Loss per share was -$2.23.
| Revenue | 1.07M |
| Gross Profit | 1.07M |
| Operating Income | -21.00M |
| Pretax Income | -19.89M |
| Net Income | -18.92M |
| EBITDA | -20.83M |
| EBIT | -21.00M |
| Loss Per Share | -$2.23 |
Full Income StatementBalance Sheet
The company has $21.97 million in cash and $47,000 in debt, giving a net cash position of $21.92 million or $2.50 per share.
| Cash & Cash Equivalents | 21.97M |
| Total Debt | 47,000 |
| Net Cash | 21.92M |
| Net Cash Per Share | $2.50 |
| Equity (Book Value) | 20.78M |
| Book Value Per Share | 2.44 |
| Working Capital | 20.57M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$16.40 million and capital expenditures -$28,000, giving a free cash flow of -$16.43 million.
| Operating Cash Flow | -16.40M |
| Capital Expenditures | -28,000 |
| Free Cash Flow | -16.43M |
| FCF Per Share | -$1.88 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -1,962.71% |
| Pretax Margin | -1,858.41% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LSTA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.15% |
| Shareholder Yield | -3.15% |
| Earnings Yield | -87.32% |
| FCF Yield | -75.82% |
Analyst Forecast
The average price target for LSTA is $23.50, which is 828.85% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $23.50 |
| Price Target Difference | 828.85% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 115.91% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 15, 2022. It was a reverse split with a ratio of 1:15.
| Last Split Date | Sep 15, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
LSTA has an Altman Z-Score of -29.55 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -29.55 |
| Piotroski F-Score | 1 |
